Ascendis Pharma ADR
(ASND)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 687,816 | 278,590 | 347,684 | 424,439 | 480,276 |
| Marketable Securities | N/A | N/A | N/A | 7,874 | 15,417 |
| Receivables | 55,367 | 86,888 | 74,578 | 60,363 | 54,456 |
| Inventories | 291,870 | 270,516 | 252,622 | 226,126 | 205,851 |
| Other current assets | -1 | 0 | 0 | 0 | 0 |
| TOTAL | $1,070,724 | $675,562 | $721,028 | $760,555 | $797,716 |
| Non-Current Assets | |||||
| PPE Net | 107,235 | 112,042 | 116,348 | 119,739 | 136,632 |
| Investments And Advances | 17,828 | 22,145 | 26,922 | 6,154 | 8,834 |
| Intangibles | 4,515 | 4,508 | 4,670 | 4,783 | 4,892 |
| Other Non-Current Assets | 2,421 | 2,354 | 2,311 | 2,302 | 2,331 |
| TOTAL | $131,999 | $141,049 | $150,251 | $132,978 | $152,690 |
| Total Assets | $1,202,724 | $816,611 | $871,279 | $893,533 | $950,405 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 679,639 | 659,759 | 691,241 | 12,150 | 12,869 |
| Accounts payable and accrued liabilities | 82,765 | 107,181 | 102,627 | 102,349 | 132,297 |
| Other current liabilities | 158,447 | 144,813 | 69,953 | 81,258 | 63,640 |
| TOTAL | $921,967 | $912,926 | $867,443 | $213,585 | $231,566 |
| Non-Current Liabilities | |||||
| Long Term Debt | 372,687 | 235,897 | 249,306 | 578,214 | 598,057 |
| Other Non-Current Liabilities | 5,498 | 5,385 | 5,429 | 259,421 | 200,706 |
| TOTAL | $387,770 | $249,513 | $262,427 | $837,635 | $798,764 |
| Total Liabilities | $1,309,737 | $1,162,439 | $1,129,870 | $1,051,221 | $1,030,329 |
| Shareholders' Equity | |||||
| Common Shares | 8,954 | 8,420 | 8,488 | 8,387 | 8,426 |
| Retained earnings | -2,801,173 | -2,664,478 | -2,595,775 | -2,464,500 | -2,399,171 |
| Other shareholders' equity | 919 | 734 | 723 | 622 | 2,254 |
| TOTAL | $-107,013 | $-345,828 | $-258,591 | $-157,688 | $-79,925 |
| Total Liabilities And Equity | $1,202,724 | $816,611 | $871,279 | $893,533 | $950,405 |